Simon Law

Dr. Simon Law


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SLSimon Law
Simon Law
KSKaren Shih
Karen Shih
DTDuc H. Tran
Duc H. Tran
ACAnne L. Coleman
Anne L. Coleman
JCJoseph Caprioli
Joseph Caprioli

1 August 2007 in Archives of Ophthalmology (1950)
Verified
Journal Article
Closed access
PDF file
SLSimon Law
Simon Law
ANAnne M. Nguyen
Anne M. Nguyen
ACAnne L. Coleman
Anne L. Coleman
JCJoseph Caprioli
Joseph Caprioli
Research from JAMA Ophthalmology — Severe Loss of Central Vision in Patients With Advanced Glaucoma Undergoing Trabeculectomy

1 April 2010 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
SLSimon Law
Simon Law
Bimatoprost in the treatment of eyelash hypotrichosis Simon K LawJules Stein Eye Institute, University of California, Los Angeles, California, USA Eyelashes hypotrichosis is a condition indicated by an inadequate amount of eyelashes. Hypertrichosis of eyelashes, characterized by excessive eyelash growth, is a regular phenomenon associated with ophthalmic prostaglandin and prostamide analogs. Recently, the US Food and Drug Administration approved Latisse® (bimatoprost 0.03% solution), identical to the ophthalmic solution for glaucoma treatment, for increasing eyelash length, thickness and darkness in patients with hypotrichosis of the eyelashes. When prostaglandin and prostamide analogs interact with the prostanoid receptors in the hair follicle, this most likely stimulates the resting follicles (telogen phase) to growing follicles (anagen phase). Prostaglandin and prostamide analogs may also prolong the anagen phase of eyelashes, leading to an increase of eyelash length. Although bimatoprost is effective in promoting increased growth of healthy eyelashes and adnexal hairs, its effectiveness in patients with eyelash alopecia areata is debatable and its protective effect is not yet studied in patients with eyelash loss secondary to radiation or chemotherapy. Bimatoprost is generally safe when applied to the base of the eyelashes at the lid margin with minimum side effects. However, other ocular or systemic side effects associated with ophthalmic prostaglandin and prostamide analogs may occur when instilled on the surface of the eye, and patients must be informed and monitored.Keywords: bimatoprost, Latisse, prostaglandin, prostamide, eyelash, hypotrichosis

1 April 2008 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SLSimon Law
Simon Law
BSBrian J. Song
Brian J. Song
FYFei Yu
Fei Yu
KKKristina Kurbanyan
Kristina Kurbanyan
TYTien-An Yang
Tien-An Yang
JCJoseph Caprioli
Joseph Caprioli

1 September 2005 in Ophthalmology
Verified
Journal Article
Closed access
SLSimon Law
Simon Law
ANAnne Nguyen
Anne Nguyen
ACAnne L. Coleman
Anne L. Coleman
JCJoseph Caprioli
Joseph Caprioli

1 June 2014 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
AKAllen Kwong
Allen Kwong
SLSimon Law
Simon Law
RKRobert R. Kule
Robert R. Kule
KNKouros Nouri-Mahdavi
Kouros Nouri-Mahdavi
ACAnne L. Coleman
Anne L. Coleman
JGJoAnn Giaconi
JoAnn Giaconi